Literature DB >> 11590368

Drug metabolism, danger signals, and drug-induced hypersensitivity.

R S Gruchalla1.   

Abstract

One of the most difficult challenges for the practicing allergist/immunologist today is that of evaluating and managing patients who present with histories of drug-induced reactions. Adverse drug reactions are heterogeneous, and a single drug can often cause a multitude of reactions. Because the mechanisms responsible for many of these reactions are not known, they can be, and often are, difficult to classify. Moreover, for those that have features consistent with immune-mediated mechanisms, our diagnostic tools remain limited, because little is known about the relevant immunogenic determinants of most drugs. Despite these challenges, management approaches must be devised for patients who present with histories of drug-induced disease. Simply telling such a patient to avoid all drugs that have been associated with previous adverse events leaves both the patient and the referring physician frustrated. The initial part of this review focuses on exciting current research that is furthering our understanding of the mechanisms responsible for drug-induced reactions. Because it will take time to translate this new information into clinical practice, the latter part of the review focuses on ways to evaluate and manage patients who present with drug-induced reactions using the tools and the knowledge that are currently available.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590368     DOI: 10.1067/mai.2001.118509

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

1.  Fatal anaphylactic reaction to intravenous cephalexin.

Authors:  Agnes L F Chan; Haw Yu Lee; Henry W C Leung
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

2.  Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.

Authors:  Payal Bhaiya; Sanjoy Roychowdhury; Piyush M Vyas; Mark A Doll; David W Hein; Craig K Svensson
Journal:  Toxicol Appl Pharmacol       Date:  2006-04-17       Impact factor: 4.219

3.  [Pulmonary infiltrates with blood eosinophilia in a 62-year-old patient].

Authors:  M Kohlhäufl; N Weber; A Morresi-Hauf; D Geiger; H Raith; K Häussinger
Journal:  Internist (Berl)       Date:  2003-08       Impact factor: 0.743

4.  Molecular modeling of penicilloate anions: an RHF-SCF analysis.

Authors:  Joel K Weltman; George B Loriot
Journal:  J Mol Model       Date:  2003-05-23       Impact factor: 1.810

Review 5.  Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.

Authors:  Osamu Matsuno
Journal:  Respir Res       Date:  2012-05-31

Review 6.  [Drug allergies. Clinical aspects, pathophysiology and treatment of cutaneous manifestations].

Authors:  B Sachs; H F Merk
Journal:  Hautarzt       Date:  2005-01       Impact factor: 1.198

Review 7.  Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back.

Authors:  Rik Schrijvers; Liesbeth Gilissen; Anca Mirela Chiriac; Pascal Demoly
Journal:  Clin Transl Allergy       Date:  2015-09-03       Impact factor: 5.871

8.  Inhibition of fibrosis and inflammation by triple therapy with pirfenidone, edaravone and erythropoietin in rabbits with drug-induced lung injury: comparison of CT imaging and pathological findings.

Authors:  Shobu Watanabe; Norihisa Nitta; Akinaga Sonoda; Ayumi Nitta-Seko; Shinichi Ohta; Keiko Tsuchiya; Hideji Otani; Yuki Tomozawa; Yukihiro Nagatani; Kenichi Mukaisho; Masashi Takahashi; Kiyoshi Murata
Journal:  Exp Ther Med       Date:  2013-09-18       Impact factor: 2.447

Review 9.  Acute interstitial nephritis - a reappraisal and update.

Authors:  Rajeev Raghavan; Garabed Eknoyan
Journal:  Clin Nephrol       Date:  2014-09       Impact factor: 0.975

Review 10.  In vitro Models to Evaluate Drug-Induced Hypersensitivity: Potential Test Based on Activation of Dendritic Cells.

Authors:  Valentina Galbiati; Angela Papale; Elena Kummer; Emanuela Corsini
Journal:  Front Pharmacol       Date:  2016-07-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.